ArticleClinical and translational medicine2026
Oncogenic driver and therapeutic target: Prolactin signalling axis in retroperitoneal sarcoma.
Fu'an Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it